Literature DB >> 10746613

Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin.

D J Sahlas1, S P Miller, M Guerin, M Veilleux, G Francis.   

Abstract

Acute disseminated encephalomyelitis (ADEM) is a presumed immune-mediated, demyelinating disease of the CNS for which the standard treatment is high-dose steroids. We describe two patients with ADEM in whom treatment with IV methylprednisolone coincided with deterioration in their clinical status. They were subsequently treated with IV immunoglobulin and exhibited dramatic clinical improvement, with return to their previous level of functioning.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10746613     DOI： 10.1212/wnl.54.6.1370

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  33 in total

Review 1.  A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.

Authors:  Christopher Eckstein; Shiv Saidha; Michael Levy
Journal:  J Neurol       Date:  2011-09-20       Impact factor: 4.849

Review 2.  Acute disseminated encephalomyelitis: recognition in the hands of general paediatricians.

Authors:  M Stonehouse; G Gupte; E Wassmer; W P Whitehouse
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

Review 3.  Acute disseminated encephalomyelitis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  2003-01       Impact factor: 2.401

Review 4.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

5.  Positive PCR for enterovirus in the cerebrospinal fluid of a child with acute disseminated encephalomyelitis.

Authors:  Paolo Mariotti; Anna Paola Batocchi; Cesare Colosimo; Paola Cattani; Maria Chiara Stefanini; Francesca Colitto; Pietro Tonali; Francesco Guzzetta
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

Review 6.  Rare indications of IVIG therapy in neurological diseases based on case reports and small studies.

Authors:  Hayrettin Tumani
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

7.  Acute demyelinating disorders of the central nervous system.

Authors:  Meghan K Harris; Amir Hadi Maghzi; Masoud Etemadifar; Roger E Kelley; Eduardo Gonzalez-Toledo; Alireza Minagar
Journal:  Curr Treat Options Neurol       Date:  2009-01       Impact factor: 3.598

8.  Acute disseminated encephalomyelitis.

Authors:  Rajesh Balu; Preeti Shanbag; Vaishali More; Mamta Vaidya
Journal:  Indian J Pediatr       Date:  2004-11       Impact factor: 1.967

Review 9.  Immunomodulatory therapies in neurologic critical care.

Authors:  Logan M McDaneld; Jeremy D Fields; Dennis N Bourdette; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2009-09-23       Impact factor: 3.210

Review 10.  Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.

Authors:  J Nicholas Brenton; Brenda L Banwell
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.